Gen-H Licenses Antibiotic-Free Fermentation Technology to Biocatalysts Ltd
Gen-H is proud to announce the successful licensing of its antibiotic-free fermentation technology to Biocatalysts Ltd, highlighting both companies’ commitment to sustainable biotechnology solutions.
At the core of this agreement is Gen-H’s antibiotic-free plasmid maintenance system – a novel expression platform that functions entirely without antibiotics or antibiotic resistance marker genes. This technology delivers a range of key advantages:
- Cost-Effective: Eliminates the need for antibiotics, reducing production costs and simplifying process management.
- Higher Productivity: Reduced metabolic burden on host cells can lead to increased protein yields.
- Enhanced Safety: The absence of antibiotics and resistance genes eliminates the risk of creating antibiotic-resistant bacteria.
- Highly Flexible: Compatible with a wide range of host strains, media, and fermentation conditions, and easily integrates into existing production systems.
This antibiotic-free fermentation platform has already proven its scalability with successful protein production for the food industry up to 10,000L scale – confirming its industrial applicability, reliability, and its potential to set a new benchmark in biotechnological manufacturing.
Contact us to learn how our green biocatalysis technologies can support and enhance your production goals.
